Doximity
DOCS
27.69
-0.10
-0.36%
Doximity
US · DOCS
#2122 by market cap
Listed 2021
27.69
-0.10
-0.36%
Live - 5344 symbols - heartbeat 168s ago
· 2026-10-08 07:38
Pre-market
27.41
-1.01%
After-hours
27.69
0.00%
Overnight
27.69
0.00%
- Market cap
- 4.94B
- P/E (TTM)i
- 32.96
- P/Bi
- 5.39
- EPSi
- 0.98
- Div yieldi
- 0.00%
- 52W posi
- 19%
Reader sentiment
Are you bullish or bearish on DOCS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 19.12, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +13.05% YoY
Margins
- Gross margin
- 89.09%
- Operating margin
- 33.33%
- Net margin
- 30.40%
Key ratios & quality
- PEG ratioi
- 1.63
- Altman Z-Scorei
- 19.12
PEG uses trailing P/E against the 3-year net income growth rate (20.23%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 85.70M | 116.39M | 206.90M | 343.55M | 419.05M | 475.42M | 570.40M | 644.86M |
| Gross profit | 74.81M | 101.49M | 175.70M | 303.76M | 365.56M | 424.75M | 514.53M | 574.54M |
| Selling & admin expenses | 40.39M | 46.89M | 78.53M | 127.88M | 160.27M | 170.96M | 191.38M | 228.92M |
| Research & development | 27.50M | 32.44M | 43.87M | 62.35M | 80.19M | 81.98M | 93.04M | 130.70M |
| Operating profit | 6.92M | 22.16M | 53.30M | 113.54M | 125.11M | 171.81M | 230.10M | 214.92M |
| Pretax profit | 7.93M | 23.51M | 57.77M | 114.01M | 133.16M | 185.20M | 263.57M | 250.01M |
| Tax | 98.00K | -6.22M | 7.56M | -40.78M | 20.34M | 37.62M | 40.39M | 53.95M |
| Net profit | 7.83M | 29.74M | 50.21M | 154.78M | 112.82M | 147.58M | 223.19M | 196.05M |
| Basic EPS | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.00 | 0.06 | 0.12 | 0.70 | 0.53 | 0.72 | 1.11 | 0.98 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 138.29M | 145.91M | 168.53M | 185.05M | 145.37M | 156.62M |
| Gross profit | 123.82M | 130.12M | 152.10M | 166.35M | 125.97M | 132.93M |
| Selling & admin expenses | 50.34M | 48.80M | 58.22M | 59.86M | 62.03M | 60.81M |
| Research & development | 24.80M | 26.80M | 30.20M | 34.60M | 39.11M | 38.48M |
| Operating profit | 48.68M | 54.52M | 63.68M | 71.90M | 24.83M | 33.64M |
| Pretax profit | 58.39M | 64.15M | 72.94M | 80.80M | 32.12M | 40.36M |
| Tax | -4.06M | 10.83M | 10.88M | 19.24M | 13.01M | 16.05M |
| Net profit | 62.46M | 53.32M | 62.06M | 61.56M | 19.11M | 24.32M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.31 | 0.27 | 0.31 | 0.31 | 0.10 | 0.13 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | 122.97M | 209.40M | 904.14M | 975.45M | 912.94M | 1.09B | 944.26M |
| Cash & ST investments | -- | 86.45M | 142.53M | 798.11M | 841.00M | 762.90M | 915.66M | 748.60M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | -- | 138.92M | 251.72M | 991.36M | 1.14B | 1.08B | 1.26B | 1.12B |
| Total current liabilities | -- | 55.71M | 102.04M | 111.28M | 139.51M | 147.25M | 156.26M | 154.97M |
| Short-term debt | -- | 1.96M | 970.00K | 642.00K | 1.75M | 2.15M | 2.21M | 2.11M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | -- | 137,784,000.00 | 184,976,000.00 | 112,763,000.00 | 170,772,000.00 | 177,977,000.00 | 181,684,000.00 | 172,850,000.00 |
| Total equity | -- | 1.14M | 66.74M | 878.59M | 966.12M | 901.40M | 1.08B | 950.84M |
| Retained earnings | -- | -13.89M | 36.32M | 191.11M | 217.86M | 79.99M | 186.89M | -51.06M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.09B | 1.03B | 1.09B | 993.45M | 944.26M | 913.98M |
| Cash & ST investments | 915.66M | 840.97M | 878.37M | 735.13M | 748.60M | 687.79M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.26B | 1.20B | 1.26B | 1.16B | 1.12B | 1.08B |
| Total current liabilities | 156.26M | 159.91M | 140.27M | 149.85M | 154.97M | 150.36M |
| Short-term debt | 2.21M | 2.17M | 2.12M | 2.08M | 2.11M | 2.14M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 181,684,000.00 | 178,852,000.00 | 161,578,000.00 | 177,728,000.00 | 172,850,000.00 | 167,775,000.00 |
| Total equity | 1.08B | 1.03B | 1.10B | 979.30M | 950.84M | 916.07M |
| Retained earnings | 186.89M | 117.11M | 157.69M | 20.97M | -51.06M | -119.04M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 15.31M | 26.20M | 82.97M | 126.58M | 179.60M | 184.10M | 273.27M | 326.46M |
| Depreciation & amortization | 551.00K | 900.00K | 3.70M | 5.04M | 10.28M | 10.27M | 10.66M | 14.38M |
| Free cash flow | 14.12M | 21.96M | 78.36M | 120.88M | 173.42M | 178.30M | 266.74M | 317.50M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -2.02M | 551.21M | -85.32M | -280.72M | -120.29M | -431.65M |
| Ending cash balance | 33.61M | 48.43M | 66.39M | 112.81M | 158.03M | 96.79M | 209.61M | 219.18M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 98.49M | 62.10M | 93.94M | 60.89M | 109.52M | 41.99M |
| Depreciation & amortization | 2.83M | 2.79M | 3.47M | 3.99M | 4.13M | 4.29M |
| Free cash flow | 96.98M | 60.14M | 91.58M | 58.52M | 107.27M | 39.60M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -26.79M | -122.36M | -21.89M | -196.88M | -90.53M | -91.63M |
| Ending cash balance | 209.61M | 137.26M | 169.25M | 64.84M | 219.18M | 273.60M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | 953.26 | 145.88 | 28.19 | 12.23 | 15.81 | 22.50 | 19.28 |
| ROA %i | -- | 7.80 | 25.35 | 21.44 | 10.60 | 13.32 | 19.05 | 16.42 |
| ROIC %i | -- | 316.73 | 137.93 | 28.12 | 11.28 | 13.73 | 19.18 | 16.35 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | 214.60 | 28.45 | 19.60 |
| EBIT margin %i | 8.08 | 19.04 | 25.76 | 33.05 | 29.86 | 36.14 | 40.34 | 33.33 |
| FCF / sales %i | 16.47 | 18.86 | 37.88 | 35.19 | 41.38 | 37.50 | 46.76 | 49.23 |
| Current ratioi | -- | 2.21 | 2.05 | 8.12 | 6.99 | 6.20 | 6.97 | 6.09 |
| Quick ratioi | -- | 2.02 | 1.89 | 7.90 | 6.80 | 5.87 | 6.68 | 5.76 |
| Debt / assetsi | -- | 1.64 | 0.50 | 0.11 | 1.38 | 1.35 | 0.98 | 0.91 |
| LT debt / equityi | -- | 28.52 | 0.43 | 0.05 | 1.44 | 1.38 | 0.94 | 0.85 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 58.86 | 53.27 | 31.96 | 18.41 | 15.45 |
| Net income CAGR (3Y) %i | -- | -- | -- | 170.35 | 55.97 | 43.25 | 12.97 | 20.23 |
| FCF CAGR (3Y) %i | -- | -- | -- | 104.59 | 99.15 | 31.53 | 30.19 | 22.33 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 22.50 | 24.25 | 24.61 | 23.82 | 19.28 | 17.21 |
| ROA %i | 19.05 | 20.64 | 21.30 | 20.56 | 16.42 | 14.60 |
| ROIC %i | 19.18 | 20.57 | 21.00 | 20.31 | 16.35 | 14.55 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 40.34 | 40.46 | 39.72 | 37.44 | 33.33 | 29.60 |
| FCF / sales %i | 46.76 | 48.73 | 50.23 | 48.17 | 49.23 | 45.30 |
| Current ratioi | 6.97 | 6.47 | 7.79 | 6.63 | 6.09 | 6.08 |
| Quick ratioi | 6.68 | 6.14 | 7.18 | 5.95 | 5.76 | 5.76 |
| Debt / assetsi | 0.98 | 0.98 | 0.90 | 0.92 | 0.91 | 0.89 |
| LT debt / equityi | 0.94 | 0.94 | 0.83 | 0.88 | 0.85 | 0.82 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 07:38:14 · For reference only, not investment advice and not tailored to your situation.